BARCLAYS PLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260409. A total of 23 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2018$02
+100.0%
0.00%
Q1 2017$010.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2017
NameSharesValueWeighting ↓
B. Riley Financial, Inc. 756,276$3,274,0000.45%
KINGDON CAPITAL MANAGEMENT, L.L.C. 64,549$279,0000.02%
Baker Brothers Advisors 510,922$2,212,0000.02%
TWO SIGMA SECURITIES, LLC 13,642$59,0000.01%
A.R.T. Advisors, LLC 38,592$167,0000.01%
OPPENHEIMER & CO INC 20,080$87,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 2,600$11,0000.00%
GLENMEDE TRUST CO NA 100$00.00%
Genovese Burford & Brothers Wealth & Retirement Plan Management, LLC 100$00.00%
DIMENSIONAL FUND ADVISORS LP 20,121$1,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders